Abbott agrees $25bn deal for St Jude Medical

Abbott agreed to pay $46.75 in cash and 0.8708 shares of its common stock for every share of St. Jude Medical. Taken together, the deal equals about $85 per share of St. Jude stock, reflecting a 37% premium on Wednesday's closing price of $61.97.

Abbott Laboratories Acquires Experimental & Applied Sciences Mergr

Julian Emanuel, U.S. equity and derivatives strategist at UBS, and Gary Shilling, president at A. Gary Shilling & Co., discuss Abbott Laboratories' agreement to buy St, Jude Medical Inc.

Abbott Laboratories to buy St. Jude Medical for $25 billion

Abbott plans to absorb or refinance St. Jude's $5.7 billion in debt and issue new debt to pay for the cash part of the acquisition.

Medical device manufacturer Abbott Laboratories has reached a deal to acquire fellow medical device maker St. Jude Medical in a cash-and-stock deal valued at $25 billion.